ImmuPharma’s McCarthy on phase III Lupuzor™ trials
3rd February 2015 - 4:08 pmTim McCarthy, Chairman of ImmuPharma (LON:IMM), discusses the upcoming Phase III clinical trial of Lupuzor.
Tim McCarthy, Chairman of ImmuPharma (LON:IMM), discusses the upcoming Phase III clinical trial of Lupuzor.